In 2005, biotech stocks performed strongly in contrast to the relatively poor performance of 2004. The market capitalization of the US biotechnology sector outperformed the DOW and the NASDAQ climbing by about 22% in 2005 compared to 11% in 2004. This increase was fueled in large part by increases...(Full transcript available to logged in subscribers.).
Register & Subscribe
Login
